Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path Publisher



Bonab MM1 ; Shakiba Y1 ; Talebian F2 ; Nikbin B1
Authors

Source: Multiple Sclerosis: A Mechanistic View Published:2016


Abstract

Multiple sclerosis (MS) is predominantly considered an immune-mediated chronic disease, with complicated pathogenesis and clinical signs of paralysis. MS is an inflammatory disease of the central nervous system in which T lymphocytes show a second phase of activation. This activation is followed by axonal demyelination and neurological disorder manifestations. In most patients, the disease is associated with axonal loss and progressive disabilities. © 2016 Elsevier Inc. All rights reserved.
Related Docs
View other Related Docs
1. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
2. Stem Cell Therapy ‒Approach for Multiple Sclerosis Treatment, Archives of Neuroscience (2016)
3. A Focus on Allogeneic Mesenchymal Stromal Cells As a Versatile Therapeutic Tool for Treating Multiple Sclerosis, Stem Cell Research and Therapy (2021)
Experts (# of related papers)
View all Related Experts
Babak Arjmand (3)
Mohammad Ali Sahraian (2)
Other Related Docs
4. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
5. Mesenchymal Stem Cells: Rising Concerns Over Their Application in Treatment of Type One Diabetes Mellitus, Journal of Diabetes Research (2015)
6. Mesenchymal Stem Cells for Multiple Sclerosis (Mesems): A Randomized, Double Blind, Cross-Over Phase I/Ii Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis, Trials (2019)
7. Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases, Handbook of Stem Cell Applications (2024)
8. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside, Iranian Journal of Kidney Diseases (2019)
9. Shining the Light on Clinical Application of Mesenchymal Stem Cell Therapy in Autoimmune Diseases, Stem Cell Research and Therapy (2022)
10. Current Advances in Stem Cell Therapy in the Treatment of Multiple Sclerosis, Reviews in the Neurosciences (2023)
11. Stem Cell Therapy for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
12. Mesenchymal Stromal Cells (Mscs) for Neurodegenerative Disease: A Promising Frontier, European Journal of Cell Biology (2020)
13. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in Patients With Multiple Sclerosis: A Pilot Study With Booster Injection, Immunological Investigations (2019)
14. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model, Molecular Neurobiology (2022)
15. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis, Molecular Neurobiology (2017)
16. Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature, Endocrine# Metabolic and Immune Disorders - Drug Targets (2022)
17. Effect of Mesenchymal Stem Cells on Glial Cells Population in Cuprizone Induced Demyelination Model, Neuropeptides (2019)
18. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
19. Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus, Iranian Journal of Public Health (2015)
20. Bone Tissue Engineering Using Human Cells: A Comprehensive Review on Recent Trends, Current Prospects, and Recommendations, Applied Sciences (Switzerland) (2019)